2020/2786(DEA) Inclusion of the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene) in the definition of 'drug' (amend. the Annex to Council Framework Decision 2004/757/JHA)
Lead committee dossier:
Progress: Procedure completed - delegated act enters into force
| Role | Committee | Rapporteur | Shadows |
|---|---|---|---|
| Lead | LIBE |
Lead committee dossier:
Subjects
Events
2020/11/17
EP - Delegated act not objected by Parliament
2020/09/16
EP - Committee referral announced in Parliament
2020/09/09
EP/CSL - Initial period for examining delegated act 2 month(s)
2020/09/02
EC - Non-legislative basic document
Documents
2020/09/02
EC - Non-legislative basic document published
Documents
Documents
- Non-legislative basic document: C(2020)05897
- Non-legislative basic document published: C(2020)05897
- Non-legislative basic document: C(2020)05897
History
(these mark the time of scraping, not the official date of the change)
2021-05-03Show (1) Changes | Timetravel
| events/2/body |
EP
|
2021-04-22Show (2) Changes | Timetravel
| events/2 |
|
| events/2 |
|
2020-12-09Show (1) Changes | Timetravel
| procedure/stage_reached |
Old
Awaiting Council decision on delegated actNew
Procedure completed - delegated act enters into force |
2020-11-17Show (2) Changes | Timetravel
| events/3 |
|
| procedure/stage_reached |
Old
Awaiting committee decisionNew
Awaiting Council decision on delegated act |
2020-09-27Show (3) Changes
| events/2 |
|
| procedure/dossier_of_the_committee |
|
| procedure/stage_reached |
Old
Preparatory phase in ParliamentNew
Awaiting committee decision |